The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.

MediPharm wins Article 117 opinion for 2027 European cannabis inhaler launch

Nov 6, 2026 00:00 (8h ago)

Verifying

MediPharm Labs received a positive Article 117 opinion for its cannabinoid inhaler platform.
2027 European sales plans cover THC 2.5 mg, THC 5 mg and balanced THC/CBD inhalers.
Blackpoint will commercialize and distribute products across the United Kingdom and Europe.